[{"id":"e6ff3938-bced-463b-b199-e7c95c862dbb","acronym":"","url":"https://clinicaltrials.gov/study/NCT05043922","created_at":"2021-09-14T16:53:26.541Z","updated_at":"2024-07-02T16:36:04.510Z","phase":"Phase 2","brief_title":"A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma","source_id_and_acronym":"NCT05043922","lead_sponsor":"Haihe Biopharma Co., Ltd.","biomarkers":" PIK3CA","pipe":" | ","alterations":" PIK3CA mutation","tags":["PIK3CA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PIK3CA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Haizexin (risovalisib)"],"overall_status":"Recruiting","enrollment":" Enrollment 86","initiation":"Initiation: 08/13/2021","start_date":" 08/13/2021","primary_txt":" Primary completion: 06/30/2023","primary_completion_date":" 06/30/2023","study_txt":" Completion: 06/30/2023","study_completion_date":" 06/30/2023","last_update_posted":"2022-09-02"},{"id":"e3cfa8cc-8d52-4944-9ec7-32fd7763112f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04856371","created_at":"2021-04-23T21:52:23.939Z","updated_at":"2024-07-02T16:36:31.285Z","phase":"Phase 1","brief_title":"Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer","source_id_and_acronym":"NCT04856371","lead_sponsor":"Haihe Biopharma Co., Ltd.","biomarkers":" HER-2 • KRAS • PIK3CA • PTEN","pipe":" | ","alterations":" HER-2 negative • PIK3CA mutation","tags":["HER-2 • KRAS • PIK3CA • PTEN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • PIK3CA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Ibrance (palbociclib) • fulvestrant • letrozole • Haizexin (risovalisib)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 228","initiation":"Initiation: 04/01/2021","start_date":" 04/01/2021","primary_txt":" Primary completion: 03/01/2022","primary_completion_date":" 03/01/2022","study_txt":" Completion: 12/01/2022","study_completion_date":" 12/01/2022","last_update_posted":"2021-04-23"}]